NCT03643484 2024-02-21
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
AstraZeneca
Completed
AstraZeneca
Centre hospitalier de l'Université de Montréal (CHUM)
St. James's Hospital, Ireland
Instituto Nacional de Cancerologia de Mexico
M.D. Anderson Cancer Center